Safety
Abaloparatide
Adverse-event report summary for Abaloparatide, drawn from the FDA Adverse Event Reporting System (FAERS).
- Total reports
- 394
- Reports flagged serious
- 331
“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.
Most frequently reported reactions
- Dizziness43 reports
- Nausea40 reports
- Headache35 reports
- Physical Deconditioning32 reports
- Palpitations29 reports
- Back Pain26 reports
- Injection Site Haemorrhage24 reports
- Injection Site Pain24 reports
- Malaise24 reports
- Blood Pressure Decreased23 reports
- Pyrexia20 reports
- Feeling Abnormal18 reports
- Injection Site Erythema17 reports
- Fall16 reports
- Vomiting16 reports
Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.